1
|
Jones J, Do V, Lu Y, van Dam RM. Accelerating radiochemistry development: Automated robotic platform for performing up to 64 droplet radiochemical reactions in a morning. Chem Eng J 2023; 468:143524. [PMID: 37576334 PMCID: PMC10421640 DOI: 10.1016/j.cej.2023.143524] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/15/2023]
Abstract
The growing discovery and development of novel radiopharmaceuticals and radiolabeling methods requires an increasing capacity for radiochemistry experiments. However, such studies typically rely on radiosynthesizers designed for clinical batch production rather than research, greatly limiting throughput. Two general solutions are being pursued to address this: developing new synthesis optimization algorithms to minimize how many experiments are needed, and developing apparatus with enhanced experiment throughput. We describe here a novel high-throughput system based on performing arrays of droplet-based reactions at 10 μL volume scale in parallel. The automatic robotic platform can perform a set of 64 experiments in ~3 h (from isotope loading to crude product, plus sampling onto TLC plates), plus ~1 h for off-line radio-TLC analysis and radioactivity measurements, rather than the weeks or months that would be needed using a conventional system. We show the high repeatability and low crosstalk of the platform and demonstrate optimization studies for two 18F-labeled tracers. This novel automated platform greatly increases the practicality of performing arrays of droplet reactions by eliminating human error, vastly reducing tedium and fatigue, minimizing radiation exposure, and freeing up radiochemist time for other intellectually valuable pursuits.
Collapse
Affiliation(s)
- Jason Jones
- Crump Institute of Molecular Imaging, University of California Los Angeles (UCLA),Los Angeles, CA, USA
- Physics and Biology in Medicine Interdepartmental Graduate Program, UCLA, USA
- Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, UCLA, US
| | - Viviann Do
- Crump Institute of Molecular Imaging, University of California Los Angeles (UCLA),Los Angeles, CA, USA
- Department of Biochemistry, UCLA, USA
| | - Yingqing Lu
- Crump Institute of Molecular Imaging, University of California Los Angeles (UCLA),Los Angeles, CA, USA
- Physics and Biology in Medicine Interdepartmental Graduate Program, UCLA, USA
- Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, UCLA, US
| | - R Michael van Dam
- Crump Institute of Molecular Imaging, University of California Los Angeles (UCLA),Los Angeles, CA, USA
- Physics and Biology in Medicine Interdepartmental Graduate Program, UCLA, USA
- Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, UCLA, US
- Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, UCLA, USA
| |
Collapse
|
2
|
Lozada J, Kuo HT, Lin WX, Lin KS, Bénard F, Perrin DM. Imidazolium-methylene-trifluoroborate: A novel radioprosthetic group validated with preclinical 18 F-Positron Emission Tomography imaging of Prostate Specific Membrane Antigen in mice. J Labelled Comp Radiopharm 2023; 66:130-137. [PMID: 36813569 DOI: 10.1002/jlcr.4020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2022] [Revised: 02/06/2023] [Accepted: 02/08/2023] [Indexed: 02/24/2023]
Abstract
Organotrifluoroborates have gained acceptance as radioprosthetic groups for radiofluorination. Of these, the zwitterionic prosthetic group "AMBF3 " with a quaternary dimethylammonium ion dominates the trifluoroborate space. Herein, we report on imidazolium-methylene trifluoroborate (ImMBF3 ) as an alternative radioprosthetic group and report on its properties in the context of a PSMA-targeting EUK ligand that was previously been conjugated to AMBF3 . The ImMBF3 is readily synthesized from imidazole and conjugated via CuAAC "click" chemistry to give a structure similar to PSMA-617. 18 F-labeling proceeded in one step per our previous reports and imaged in LNCaP-xenograft bearing mice. The [18 F]-PSMA-617-ImMBF3 tracer proved to be less polar (LogP7.4 = -2.95 ± 0.03) while showing a significantly lower solvolytic rate (t1/2 = 8100 min) and slightly higher molar activity (Am) at 174 ± 38 GBq/μmol. Tumor uptake was measured at 13.7 ± 4.8%ID/g and a tumor:muscle ratio of 74.2 ± 35.0, tumor:blood ratio of 21.4 ± 7.0, tumor:kidney ratio of 0.29 ± 0.14, and tumor:bone ratio of 23.5 ± 9.5. In comparison with previously reported PSMA-targeting EUK-AMBF3 conjugates, we have altered the LogP7.4 value, tuned the solvolytic half-life of the prosthetic, and increased radiochemical conversion while achieving similar tumor uptake, contrast ratios, and molar activities compared with AMBF3 bioconjugates.
Collapse
Affiliation(s)
- Jerome Lozada
- Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada
| | - Hsiou-Ting Kuo
- Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada
| | - Wen Xuan Lin
- Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada
| | - Kuo-Shyan Lin
- Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada
| | - François Bénard
- Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada
| | - David M Perrin
- Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
3
|
Abstract
18F-Labeling methods for the preparation of 18F-labeled molecular probes can be classified into electrophilic fluorination, nucleophilic fluorination, metal-F coordination, and 18F/19F isotope exchange. Isotope exchange-based 18F-labeling methods demonstrate mild conditions featuring water resistance and facile high-performance liquid chromatography-free purification in direct 18F-labeling of substrates. This paper systematically reviews isotope exchange-based 18F-labeling methods sorted by the adjacent atom bonding with F, i.e., carbon and noncarbon atoms (Si, B, P, S, Ga, Fe, etc.). The respective isotope exchange mechanism, radiolabeling condition, radiochemical yield, molar activity, and stability of the 18F-product are mainly discussed for each isotope exchange-based 18F-labeling method as well as the cutting-edge application of the corresponding 18F-labeled molecular probes.
Collapse
Affiliation(s)
- Tao Wang
- Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Department of Experimental Medicine, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China
| | - Shengji Lv
- Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Department of Experimental Medicine, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China
| | - Zhaobiao Mou
- Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Department of Experimental Medicine, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China
| | - Zhenru Zhang
- Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Department of Experimental Medicine, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China
| | - Taotao Dong
- Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Department of Experimental Medicine, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China
| | - Zijing Li
- Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Department of Experimental Medicine, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China
| |
Collapse
|
4
|
Dam JH, Langkjær N, Baun C, Olsen BB, Nielsen AY, Thisgaard H. Preparation and Evaluation of [18F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [68Ga]Ga-DOTA/NOTA-NOC. Molecules 2022; 27:molecules27206818. [PMID: 36296411 PMCID: PMC9609173 DOI: 10.3390/molecules27206818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2022] [Revised: 10/07/2022] [Accepted: 10/08/2022] [Indexed: 11/16/2022] Open
Abstract
Background: The somatostatin receptors 1–5 are overexpressed on neuroendocrine neoplasms and, as such, represent a favorable target for molecular imaging. This study investigates the potential of [18F]AlF-NOTA-[1-Nal3]-Octreotide and compares it in vivo to DOTA- and NOTA-[1-Nal3]-Octreotide radiolabeled with gallium-68. Methods: DOTA- and NOTA-NOC were radiolabeled with gallium-68 and NOTA-NOC with [18F]AlF. Biodistributions of the three radioligands were evaluated in AR42J xenografted mice at 1 h p.i and for [18F]AlF at 3 h p.i. Preclinical PET/CT was applied to confirm the general uptake pattern. Results: Gallium-68 was incorporated into DOTA- and NOTA-NOC in yields and radiochemical purities greater than 96.5%. NOTA-NOC was radiolabeled with [18F]AlF in yields of 38 ± 8% and radiochemical purity above 99% after purification. The biodistribution in tumor-bearing mice showed a high uptake in tumors of 26.4 ± 10.8 %ID/g for [68Ga]Ga-DOTA-NOC and 25.7 ± 5.8 %ID/g for [68Ga]Ga-NOTA-NOC. Additionally, [18F]AlF-NOTA-NOC exhibited a tumor uptake of 37.3 ± 10.5 %ID/g for [18F]AlF-NOTA-NOC, which further increased to 42.1 ± 5.3 %ID/g at 3 h p.i. Conclusions: The high tumor uptake of all radioligands was observed. However, [18F]AlF-NOTA-NOC surpassed the other clinically well-established radiotracers in vivo, especially at 3 h p.i. The tumor-to-blood and -liver ratios increased significantly over three hours for [18F]AlF-NOTA-NOC, making it possible to detect liver metastases. Therefore, [18F]AlF demonstrates promise as a surrogate pseudo-radiometal to gallium-68.
Collapse
Affiliation(s)
- Johan Hygum Dam
- Department of Nuclear Medicine, Odense University Hospital, Kløvervænget 47, DK-5000 Odense, Denmark
- Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19, DK-5000 Odense, Denmark
- Correspondence:
| | - Niels Langkjær
- Department of Nuclear Medicine, Odense University Hospital, Kløvervænget 47, DK-5000 Odense, Denmark
| | - Christina Baun
- Department of Nuclear Medicine, Odense University Hospital, Kløvervænget 47, DK-5000 Odense, Denmark
| | - Birgitte Brinkmann Olsen
- Department of Surgical Pathology, Zealand University Hospital, Sygehusvej 10, DK-4000 Roskilde, Denmark
| | - Aaraby Yoheswaran Nielsen
- Department of Nuclear Medicine, Odense University Hospital, Kløvervænget 47, DK-5000 Odense, Denmark
| | - Helge Thisgaard
- Department of Nuclear Medicine, Odense University Hospital, Kløvervænget 47, DK-5000 Odense, Denmark
- Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19, DK-5000 Odense, Denmark
| |
Collapse
|
5
|
Elkawad H, Xu Y, Tian M, Jin C, Zhang H, Yu K, He Q. Recent advances in microfluidic devices for radiosynthesis of PET‐imaging probes. Chem Asian J 2022; 17:e202200579. [PMID: 35909081 DOI: 10.1002/asia.202200579] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Revised: 07/29/2022] [Indexed: 11/06/2022]
Affiliation(s)
- Husamelden Elkawad
- The second affiliated hospital of Zhejiang University Nuclear Medicine and PET center CHINA
| | - Yangyang Xu
- Zhejiang University b. College of Chemical & Biological Engineering CHINA
| | - Mei Tian
- The second affiliated hospital of Zhejiang University Nuclear Medicine & PET center CHINA
| | - Chenyang Jin
- Zhejiang University b. College of Chemical & Biological Engineering CHINA
| | - Hong Zhang
- The second affiliated hospital of Zhejiang University b. College of Chemical & Biological Engineering CHINA
| | - Kaiwu Yu
- Zhejiang University b. College of Chemical & Biological Engineering CHINA
| | - Qinggang He
- Zhejiang University Chemical Engineering 38 Zheda Rd. 310027 Hangzhou CHINA
| |
Collapse
|
6
|
Otaru S, Paulus A, Imlimthan S, Kuurne I, Virtanen H, Liljenbäck H, Tolvanen T, Auchynnikava T, Roivainen A, Helariutta K, Sarparanta M, Airaksinen AJ. Development of [ 18F]AmBF 3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [ 18F]AmBF 3-PEG 7-Tyr 3-Octreotide in an AR42J Pancreatic Carcinoma Model. Bioconjug Chem 2022; 33:1393-1404. [PMID: 35709482 PMCID: PMC9305971 DOI: 10.1021/acs.bioconjchem.2c00231] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Radiolabeled peptides have emerged as highly specific agents for targeting receptors expressed in tumors for therapeutic and diagnostic purposes. Peptides developed for positron emission tomography (PET) are typically radiolabeled using prosthetic groups or bifunctional chelators for fast "kit-like" incorporation of the radionuclide into the structure. A novel [18F]alkylammoniomethyltrifluoroborate ([18F]AmBF3) tetrazine (Tz), [18F]AmBF3-Tz, was developed for the [18F]fluorination of trans-cyclooctene (TCO)-modified biomolecules using Tyr3-octreotides (TOCs) as model peptides. [18F]AmBF3-Tz (Am = 15.4 ± 9.2 GBq/μmol, n = 14) was evaluated in healthy mice by ex vivo biodistribution and PET/computed tomography (CT), where the radiolabel in the prosthetic group was found stable in vivo, indicated by the low bone uptake in tibia (0.4 ± 0.1% ID/g, t = 270 min). TCO-TOCs tailored with polyethylene glycol (PEG) linkers were radiolabeled with [18F]AmBF3-Tz, forming two new tracers, [18F]AmBF3-PEG4-TOC (Am = 2.8 ± 1.8 GBq/μmol, n = 3) and [18F]AmBF3-PEG7-TOC (Am of 6.0 ± 3.4 GBq/μmol, n = 13), which were evaluated by cell uptake studies and ex vivo biodistribution in subcutaneous AR42J rat pancreatic carcinoma tumor-bearing nude mice. The tracer demonstrating superior behavior ex vivo, the [18F]AmBF3-PEG7-TOC, was further evaluated with PET/CT, where the tracer provided clear tumor visualization (SUVbaseline = 1.01 ± 0.07, vs SUVblocked = 0.76 ± 0.04) at 25 min post injection. The novel AmBF3-Tz demonstrated that it offers potential as a prosthetic group for rapid radiolabeling of biomolecules in mild conditions using bioorthogonal chemistry.
Collapse
Affiliation(s)
- Sofia Otaru
- Radiochemistry,
Department of Chemistry, University of Helsinki, P.O. Box 55, FI-00014 Helsinki, Finland
| | - Andreas Paulus
- Radiochemistry,
Department of Chemistry, University of Helsinki, P.O. Box 55, FI-00014 Helsinki, Finland
| | - Surachet Imlimthan
- Radiochemistry,
Department of Chemistry, University of Helsinki, P.O. Box 55, FI-00014 Helsinki, Finland
| | - Iida Kuurne
- Radiochemistry,
Department of Chemistry, University of Helsinki, P.O. Box 55, FI-00014 Helsinki, Finland
| | - Helena Virtanen
- Turku
PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland
| | - Heidi Liljenbäck
- Turku
PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland
- Turku
Center for Disease Modeling, Institute of Biomedicine, University of Turku, FI-20520 Turku, Finland
| | - Tuula Tolvanen
- Turku
PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland
- Department
of Medical Physics, Turku University Hospital, FI-20521 Turku, Finland
| | - Tatsiana Auchynnikava
- Turku
PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland
- Department
of Chemistry, University of Turku, FI-20014 Turku, Finland
| | - Anne Roivainen
- Turku
PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland
- Turku
Center for Disease Modeling, Institute of Biomedicine, University of Turku, FI-20520 Turku, Finland
| | - Kerttuli Helariutta
- Radiochemistry,
Department of Chemistry, University of Helsinki, P.O. Box 55, FI-00014 Helsinki, Finland
| | - Mirkka Sarparanta
- Radiochemistry,
Department of Chemistry, University of Helsinki, P.O. Box 55, FI-00014 Helsinki, Finland
| | - Anu J. Airaksinen
- Radiochemistry,
Department of Chemistry, University of Helsinki, P.O. Box 55, FI-00014 Helsinki, Finland
- Turku
PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland
- Department
of Chemistry, University of Turku, FI-20014 Turku, Finland
| |
Collapse
|
7
|
Rios A, Holloway TS, Chao PH, De Caro C, Okoro CC, van Dam RM. Microliter-scale reaction arrays for economical high-throughput experimentation in radiochemistry. Sci Rep 2022; 12:10263. [PMID: 35715457 DOI: 10.1038/s41598-022-14022-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Accepted: 05/31/2022] [Indexed: 01/14/2023] Open
Abstract
The increasing number of positron-emission tomography (PET) tracers being developed to aid drug development and create new diagnostics has led to an increased need for radiosynthesis development and optimization. Current radiosynthesis instruments are designed to produce large-scale clinical batches and are often limited to performing a single synthesis before they must be decontaminated by waiting for radionuclide decay, followed by thorough cleaning or disposal of synthesizer components. Though with some radiosynthesizers it is possible to perform a few sequential radiosyntheses in a day, none allow for parallel radiosyntheses. Throughput of one or a few experiments per day is not well suited for rapid optimization experiments. To combat these limitations, we leverage the advantages of droplet-radiochemistry to create a new platform for high-throughput experimentation in radiochemistry. This system contains an array of 4 heaters, each used to heat a set of 16 reactions on a small chip, enabling 64 parallel reactions for the rapid optimization of conditions in any stage of a multi-step radiosynthesis process. As examples, we study the syntheses of several 18F-labeled radiopharmaceuticals ([18F]Flumazenil, [18F]PBR06, [18F]Fallypride, and [18F]FEPPA), performing > 800 experiments to explore the influence of parameters including base type, base amount, precursor amount, solvent, reaction temperature, and reaction time. The experiments were carried out within only 15 experiment days, and the small volume (~ 10 μL compared to the ~ 1 mL scale of conventional instruments) consumed ~ 100 × less precursor per datapoint. This new method paves the way for more comprehensive optimization studies in radiochemistry and substantially shortening PET tracer development timelines.
Collapse
|
8
|
Wang J, van Dam RM. Economical Production of Radiopharmaceuticals for Preclinical Imaging Using Microdroplet Radiochemistry. Methods Mol Biol 2022; 2393:813-828. [PMID: 34837213 DOI: 10.1007/978-1-0716-1803-5_43] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
The short-lived radiolabeled "tracers" needed for performing whole body imaging in animals or patients with positron-emission tomography (PET) are generally produced via automated "radiosynthesizers". Most current radiosynthesizers are designed for routine production of relatively large clinical batches and are very wasteful when only a small batch of a tracer is needed, such as is the case for preclinical in vivo PET imaging studies. To overcome the prohibitively high cost of producing small batches of PET tracers, we developed a droplet microreactor system that performs radiochemistry at the 1-10μL scale instead of the milliliter scale of conventional technologies. The overall yield for the droplet-based production of many PET tracers is comparable to conventional approaches, but 10-100× less reagents are consumed, the synthesis can be completed in much less time (<30 min), and only a small laboratory footprint and minimal radiation shielding are needed. By combining these advantages, droplet microreactors enable the economical production of small batches PET tracers on demand. Here, we describe the fabrication method of the droplet microreactor and the droplet-based synthesis of an example radiotracer ([18F]fallypride).
Collapse
Affiliation(s)
- Jia Wang
- Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, CA, USA
- Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA
- Bioengineering Department, University of California Los Angeles, Los Angeles, CA, USA
| | - R Michael van Dam
- Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, CA, USA.
- Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA.
- Bioengineering Department, University of California Los Angeles, Los Angeles, CA, USA.
| |
Collapse
|
9
|
Cheng H, Liu H, Li W, Li M. Recent advances in magnetic digital microfluidic platforms. Electrophoresis 2021; 42:2329-2346. [PMID: 34196022 DOI: 10.1002/elps.202100088] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 06/22/2021] [Accepted: 06/25/2021] [Indexed: 12/14/2022]
Abstract
Magnetic Digital microfluidics (DMF), which enables the manipulation of droplets containing different types of samples and reagents by permanent magnets or electromagnet arrays, has been used as a promising platform technology for bioanalytical and preparative assays. This is due to its unique advantages such as simple and "power free" operation, easy assembly, great compatibility with auto control systems, and dual functionality of magnetic particles (actuation and target attachment). Over the past decades, magnetic DMF technique has gained a widespread attention in many fields such as sample-to-answer molecular diagnostics, immunoassays, cell assays, on-demand chemical synthesis, and single-cell manipulation. In the first part of this review, we summarised features of magnetic DMF. Then, we introduced the actuation mechanisms and fabrication of magnetic DMF. Furthermore, we discussed five main applications of magnetic DMF, namely drug screening, protein assays, polymerase chain reaction (PCR), cell manipulation, and chemical analysis and synthesis. In the last part of the review, current challenges and limitations with magnetic DMF technique were discussed, such as biocompatibility, automation of microdroplet control systems, and microdroplet evaporation, with an eye on towards future development.
Collapse
Affiliation(s)
- Hao Cheng
- Laboratoire de Thermique et Energie de Nantes (LTEN), UMR CNRS 6607, Polytech' Nantes-Université de Nantes, Nantes Cedex 03, France.,School of Mechanical, Materials, Mechatronic and Biomedical Engineering, University of Wollongong, Wollongong, Australia
| | - Hangrui Liu
- Department of Physics and Astronomy, Macquarie University, Sydney, New South Wales, Australia
| | - Weihua Li
- School of Mechanical, Materials, Mechatronic and Biomedical Engineering, University of Wollongong, Wollongong, Australia
| | - Ming Li
- School of Engineering, Macquarie University, Sydney, New South Wales, Australia.,Biomolecular Discovery Research Centre, Macquarie University, Sydney, New South Wales, Australia
| |
Collapse
|
10
|
Rios A, Holloway TS, Wang J, van Dam RM. Optimization of Radiochemical Reactions using Droplet Arrays. J Vis Exp 2021:10.3791/62056. [PMID: 33645586 PMCID: PMC8253531 DOI: 10.3791/62056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022] Open
Abstract
Current automated radiosynthesizers are designed to produce large clinical batches of radiopharmaceuticals. They are not well suited for reaction optimization or novel radiopharmaceutical development since each data point involves significant reagent consumption, and contamination of the apparatus requires time for radioactive decay before the next use. To address these limitations, a platform for performing arrays of miniature droplet-based reactions in parallel, each confined within a surface-tension trap on a patterned polytetrafluoroethylene-coated silicon "chip", was developed. These chips enable rapid and convenient studies of reaction parameters including reagent concentrations, reaction solvent, reaction temperature and time. This platform permits the completion of hundreds of reactions in a few days with minimal reagent consumption, instead of taking months using a conventional radiosynthesizer.
Collapse
Affiliation(s)
- Alejandra Rios
- Physics and Biology in Medicine Interdepartmental Graduate Program, University of California Los Angeles (UCLA); Crump Institute of Molecular Imaging, UCLA
| | - Travis S Holloway
- Crump Institute of Molecular Imaging, UCLA; Department of Molecular & Medical Pharmacology, David Geffen School of Medicine
| | - Jia Wang
- Crump Institute of Molecular Imaging, UCLA; Department of Bioengineering, UCLA
| | - R Michael van Dam
- Physics and Biology in Medicine Interdepartmental Graduate Program, University of California Los Angeles (UCLA); Crump Institute of Molecular Imaging, UCLA; Department of Molecular & Medical Pharmacology, David Geffen School of Medicine; Department of Bioengineering, UCLA;
| |
Collapse
|
11
|
Al-Qahtani M, Behe M, Bormans G, Carlucci G, Dasilva J, Decristoforo C, Elsinga PH, Kopka K, Li XG, Mach R, Middel O, Passchier J, Patt M, Penuelas I, Rey A, Scott PJH, Todde S, Toyohara J, Vugts D. Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January-June 2020). EJNMMI Radiopharm Chem 2021; 6:5. [PMID: 33507426 PMCID: PMC7843736 DOI: 10.1186/s41181-020-00118-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2020] [Accepted: 12/26/2020] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to describe trends in the field. RESULTS This commentary of highlights has resulted in 19 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. CONCLUSION Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.
Collapse
Affiliation(s)
| | - Martin Behe
- Paul Scherrer Institute, Villigen, Switzerland
| | - Guy Bormans
- Katholieke Universiteit Leuven, Leuven, Belgium
| | - Giuseppe Carlucci
- UCLA Molecular and Medical Pharmacology Department, Los Angeles, USA
| | | | | | - Philip H. Elsinga
- Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, The Netherlands
| | - Klaus Kopka
- Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany
| | | | - Robert Mach
- University of Pennsylvania, Philadelphia, USA
| | - Oskar Middel
- St Olavs Hospital and Norges teknisk-naturvitenskapelige universitet (NTNU), Trondheim, Norway
| | | | | | | | - Ana Rey
- Universidad de la Republica, Montevideo, Uruguay
| | | | - Sergio Todde
- Tecnomed Foundation, University of Milano - Bicocca, Milan, Italy
| | - Jun Toyohara
- Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
| | | |
Collapse
|
12
|
Lisova K, Wang J, Chao PH, van Dam RM. A simple and efficient automated microvolume radiosynthesis of [ 18F]Florbetaben. EJNMMI Radiopharm Chem 2020; 5:30. [PMID: 33275179 PMCID: PMC7718361 DOI: 10.1186/s41181-020-00113-w] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2020] [Accepted: 11/20/2020] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND Current automated radiosynthesizers are generally optimized for producing large batches of PET tracers. Preclinical imaging studies, however, often require only a small portion of a regular batch, which cannot be economically produced on a conventional synthesizer. Alternative approaches are desired to produce small to moderate batches to reduce cost and the amount of reagents and radioisotope needed to produce PET tracers with high molar activity. In this work we describe the first reported microvolume method for production of [18F]Florbetaben for use in imaging of Alzheimer's disease. PROCEDURES The microscale synthesis of [18F]Florbetaben was adapted from conventional-scale synthesis methods. Aqueous [18F]fluoride was azeotropically dried with K2CO3/K222 (275/383 nmol) complex prior to radiofluorination of the Boc-protected precursor (80 nmol) in 10 μL DMSO at 130 °C for 5 min. The resulting intermediate was deprotected with HCl at 90 °C for 3 min and recovered from the chip in aqueous acetonitrile solution. The crude product was purified via analytical scale HPLC and the collected fraction reformulated via solid-phase extraction using a miniature C18 cartridge. RESULTS Starting with 270 ± 100 MBq (n = 3) of [18F]Fluoride, the method affords formulated product with 49 ± 3% (decay-corrected) yield,> 98% radiochemical purity and a molar activity of 338 ± 55 GBq/μmol. The miniature C18 cartridge enables efficient elution with only 150 μL of ethanol which is diluted to a final volume of 1.0 mL, thus providing a sufficient concentration for in vivo imaging. The whole procedure can be completed in 55 min. CONCLUSIONS This work describes an efficient and reliable procedure to produce [18F]Florbetaben in quantities sufficient for large-scale preclinical applications. This method provides very high yields and molar activities compared to reported literature methods. This method can be applied to higher starting activities with special consideration given to automation and radiolysis prevention.
Collapse
Affiliation(s)
- Ksenia Lisova
- Physics & Biology in Medicine Interdepartmental Graduate Program, University of California Los Angeles, Los Angeles, CA, USA
- Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, CA, USA
- Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA
| | - Jia Wang
- Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, CA, USA
- Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA
- Department of Bioengineering, University of California Los Angeles, Los Angeles, CA, USA
| | - Philip H Chao
- Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, CA, USA
- Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA
- Department of Bioengineering, University of California Los Angeles, Los Angeles, CA, USA
| | - R Michael van Dam
- Physics & Biology in Medicine Interdepartmental Graduate Program, University of California Los Angeles, Los Angeles, CA, USA.
- Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, CA, USA.
- Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA.
- Department of Bioengineering, University of California Los Angeles, Los Angeles, CA, USA.
| |
Collapse
|
13
|
Pérez DJ, Ávila-rodríguez MA. Methods to radiolabel somatostatin analogs with [18F]fluoride: current status, challenges, and progress in clinical applications. J Radioanal Nucl Chem 2020; 326:1519-1542. [DOI: 10.1007/s10967-020-07437-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
14
|
Zhang M, Li S, Zhang H, Xu H. Research progress of 18F labeled small molecule positron emission tomography (PET) imaging agents. Eur J Med Chem 2020; 205:112629. [PMID: 32956956 DOI: 10.1016/j.ejmech.2020.112629] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2020] [Revised: 06/07/2020] [Accepted: 06/28/2020] [Indexed: 01/12/2023]
Abstract
With the development of positron emission tomography (PET) technology, a variety of PET imaging agents labeled with radionuclide 18F have been developed and widely used in the diagnosis and treatment of various clinical diseases in recent years. For example, they have showed a great value of study in the field of tumor detection, tumor treatment and evaluation of tumor therapy in a non-invasive, qualitative and quantitative way. In this review, we highlight the recent development in chemical synthesis, structure and characterization, imaging characterization, and potential applications of these 18F labeled small molecule PET imaging agents for the past five years. The development and application of 18F labeled small molecules will expand our knowledge of the function and distribution of diseases-related molecular targets and shed light on the diagnosis and treatment of various diseases including tumors.
Collapse
|
15
|
Iwata R, Terasaki K, Ishikawa Y, Harada R, Furumoto S, Yanai K, Pascali C. A concentration-based microscale method for 18F-nucleophilic substitutions and its testing on the one-pot radiosynthesis of [ 18F]FET and [ 18F]fallypride. Appl Radiat Isot 2020; 166:109361. [PMID: 32877862 DOI: 10.1016/j.apradiso.2020.109361] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Revised: 07/23/2020] [Accepted: 07/27/2020] [Indexed: 10/23/2022]
Abstract
When applied to a radiosynthesis, a microscale approach can help to save precursor and improve yields. Thus, a 5-10 μL microscale method based on a concentration procedure was developed and applied to the radiosynthesis of [18F]FET and [18F]fallypride. In spite of using an amount of precursor ca. 100 times smaller, radiochemical yields were comparable or even higher than those reported in literature. Because of the very low reaction volumes, the possible effects of concentrated dose of activity and carrier fluoride were also investigated.
Collapse
Affiliation(s)
- Ren Iwata
- Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
| | | | - Yoichi Ishikawa
- Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
| | - Ryuichi Harada
- Graduate School of Medicine, Tohoku University, Sendai, Japan
| | - Shozo Furumoto
- Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
| | - Kazuhiko Yanai
- Graduate School of Medicine, Tohoku University, Sendai, Japan
| | - Claudio Pascali
- Fondazione IRCCS Istituto Nazionale dei Tumori, V. Venezian, 1, Milan, 20133, Italy.
| |
Collapse
|
16
|
Mukai H, Watanabe Y. Review: PET imaging with macro- and middle-sized molecular probes. Nucl Med Biol 2020; 92:156-170. [PMID: 32660789 DOI: 10.1016/j.nucmedbio.2020.06.007] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2020] [Revised: 06/22/2020] [Accepted: 06/22/2020] [Indexed: 12/16/2022]
Abstract
Recent progress in radiolabeling of macro- and middle-sized molecular probes has been extending possibilities to use PET molecular imaging for dynamic application to drug development and therapeutic evaluation. Theranostics concept also accelerated the use of macro- and middle-sized molecular probes for sharpening the contrast of proper target recognition even the cellular types/subtypes and proper selection of the patients who should be treated by the same molecules recognition. Here, brief summary of the present status of immuno-PET, and then further development of advanced technologies related to immuno-PET, peptidic PET probes, and nucleic acids PET probes are described.
Collapse
Affiliation(s)
- Hidefumi Mukai
- Laboratory for Molecular Delivery and Imaging Technology, RIKEN Center for Biosystems Dynamics Research, 6-7-3 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.
| | - Yasuyoshi Watanabe
- Laboratory for Pathophysiological and Health Science, RIKEN Center for Biosystems Dynamics Research, 6-7-3 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.
| |
Collapse
|
17
|
Lau J, Pan J, Rousseau E, Uribe CF, Seelam SR, Sutherland BW, Perrin DM, Lin KS, Bénard F. Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [ 18F]AmBF 3-TATE. EJNMMI Res 2020; 10:25. [PMID: 32189151 PMCID: PMC7080905 DOI: 10.1186/s13550-020-0611-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2019] [Accepted: 02/18/2020] [Indexed: 12/14/2022] Open
Abstract
Introduction [18F]AmBF3-TATE is a somatostatin agonist that selectively binds to somatostatin receptor subtype 2 (SSTR2). For clinical translation, pharmacokinetics, radiation dosimetry, and acute toxicity of [18F]AmBF3-TATE were assessed with good laboratory practice (GLP) standards. Methods ICR mice were intravenously administered 0.8–2.0 MBq of [18F]AmBF3-TATE, with one group pre-injected with 100 μg of [19F]AmBF3-TATE 30 min before radiopharmaceutical administration to assess uptake specificity. The mice were euthanized at 0.5, 1, 2, or 4 h post-injection (p.i.). Blood and tissues were collected, weighed, and counted on a gamma counter to determine percentage injected dose per gram (%ID/g). Dosimetry was calculated based on biodistribution data using the mouse and human phantoms included in OLINDA. Acute toxicity was assessed in Sprague-Dawley rats at the dose of 0.742 mg/kg [19F]AmBF3-TATE, with a 14-day observation/recovery period. Blood chemistry parameters, gross, and histopathology were evaluated. Body weight change and food consumption were monitored. The production of [18F]AmBF3-TATE was automated on a Trasis AllinOne synthesis module. Results [18F]AmBF3-TATE was cleared through the renal and hepatobiliary pathway. At 1 h p.i., the pancreas (F, 15.7 ± 3.72 and M 14.3 ± 1.61 %ID/g), stomach (F, 15.3 ± 3.63 and M, 19.0 ± 3.49 %ID/g), and lungs (F, 9.26 ± 2.24 and M, 6.17 ± 6.04 %ID/g) were the organs with the highest specific uptake. Pre-injection with [19F]AmBF3-TATE significantly reduced pancreatic uptake (F, 0.13 ± 0.03 and M, 0.18 ± 0.09 %ID/g) at 1 h p.i. For dosimetry extrapolated to the average adult human, the bladder (0.027–0.030 mGy/MBq), pancreas (0.018–0.028 mGy/MBq), and lungs (0.006–0.013 mGy/MBq) are expected to receive the highest doses. No test-item related effects were observed upon evaluation of clinical observations, body weights, food consumption, clinical pathology, gross pathology, and histopathology for acute toxicity. [18F]AmBF3-TATE was produced at activity yields of 15.6 ± 4.59 GBq, average molar activity of 435 ± 162 GBq/μmol, and radiochemical purity of 98.0 ± 1.73% with the automated synthesizer. Conclusion [18F]AmBF3-TATE binds specifically to SSTR2. At 1000× clinical dose, [19F]AmBF3-TATE was well tolerated with no treatment-related adverse effects.
Collapse
Affiliation(s)
- Joseph Lau
- Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada
| | - Jinhe Pan
- Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada.,Department of Functional Imaging, BC Cancer, Vancouver, BC, Canada
| | - Etienne Rousseau
- Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada
| | - Carlos F Uribe
- Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada
| | | | - Brent W Sutherland
- Department of Experimental Therapeutics, BC Cancer, Vancouver, BC, Canada
| | - David M Perrin
- Department of Chemistry, University of British Columbia, Vancouver, BC, Canada
| | - Kuo-Shyan Lin
- Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada. .,Department of Functional Imaging, BC Cancer, Vancouver, BC, Canada.
| | - François Bénard
- Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada. .,Department of Functional Imaging, BC Cancer, Vancouver, BC, Canada.
| |
Collapse
|
18
|
Wang J, van Dam RM. High-Efficiency Production of Radiopharmaceuticals via Droplet Radiochemistry: A Review of Recent Progress. Mol Imaging 2020; 19:1536012120973099. [PMID: 33296272 PMCID: PMC7731702 DOI: 10.1177/1536012120973099] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Revised: 09/02/2020] [Accepted: 10/12/2020] [Indexed: 12/13/2022] Open
Abstract
New platforms are enabling radiochemistry to be carried out in tiny, microliter-scale volumes, and this capability has enormous benefits for the production of radiopharmaceuticals. These droplet-based technologies can achieve comparable or better yields compared to conventional methods, but with vastly reduced reagent consumption, shorter synthesis time, higher molar activity (even for low activity batches), faster purification, and ultra-compact system size. We review here the state of the art of this emerging direction, summarize the radiotracers and prosthetic groups that have been synthesized in droplet format, describe recent achievements in scaling up activity levels, and discuss advantages and limitations and the future outlook of these innovative devices.
Collapse
Affiliation(s)
- Jia Wang
- Crump Institute for Molecular Imaging and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA, Los Angeles, CA, USA
| | - R. Michael van Dam
- Crump Institute for Molecular Imaging and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA, Los Angeles, CA, USA
| |
Collapse
|
19
|
Wang J, Chao PH, Slavik R, van Dam RM. Multi-GBq production of the radiotracer [18F]fallypride in a droplet microreactor. RSC Adv 2020; 10:7828-7838. [PMID: 35492189 PMCID: PMC9049805 DOI: 10.1039/d0ra01212b] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Accepted: 02/11/2020] [Indexed: 12/17/2022] Open
Abstract
Microfluidics offers numerous advantages for the synthesis of short-lived radiolabeled imaging tracers: performing 18F-radiosyntheses in microliter-scale droplets has exhibited high efficiency, speed, and molar activity as well as low reagent consumption. However, most reports have been at the preclinical scale. In this study we integrate a [18F]fluoride concentrator and a microdroplet synthesizer to explore the possibility of synthesizing patient doses and multi-patient batches of clinically-acceptable tracers. In the integrated system, [18F]fluoride (up to 41 GBq [1.1 Ci]) in [18O]H2O (1 mL) was first concentrated ∼80-fold and then efficiently transferred to the 8 μL reaction chip as a series of small (∼0.5 μL) droplets. Each droplet rapidly dried at the reaction site of the pre-heated chip, resulting in localized accumulation of large amounts of radioactivity in the form of dried [18F]TBAF complex. The PET tracer [18F]fallypride was synthesized from this concentrated activity in an overall synthesis time of ∼50 min (including radioisotope concentration and transfer, droplet radiosynthesis, purification, and formulation), in amounts up to 7.2 GBq [0.19 Ci], sufficient for multiple clinical PET scans. The resulting batches of [18F]fallypride passed all QC tests needed to ensure safety for clinical injection. This integrated technology enabled for the first time the impact of a wide range of activity levels on droplet radiosynthesis to be studied. Furthermore, this substantial increase in scale expands the applications of droplet radiosynthesis to the production of clinically-relevant amounts of radiopharmaceuticals, and potentially even centralized production of clinical tracers in radiopharmacies. The overall system could be applied to fundamental studies of droplet-based radiochemical reactions, or to the production of radiopharmaceuticals labeled with a variety of isotopes used for imaging and/or targeted radiotherapeutics. Using a micro-cartridge based radionuclide concentrator enables the production of multiple (10 s) of clinical doses of the PET tracer [18F]fallypride with a droplet micro-reactor platform (8 μL).![]()
Collapse
Affiliation(s)
- Jia Wang
- Department of Bioengineering
- Henry Samueli School of Engineering
- UCLA
- Los Angeles
- USA
| | - Philip H. Chao
- Department of Bioengineering
- Henry Samueli School of Engineering
- UCLA
- Los Angeles
- USA
| | - Roger Slavik
- Ahmanson Translational Imaging Division
- David Geffen School of Medicine
- University of California
- Los Angeles
- USA
| | - R. Michael van Dam
- Department of Bioengineering
- Henry Samueli School of Engineering
- UCLA
- Los Angeles
- USA
| |
Collapse
|
20
|
Davern S, O’Neil D, Hallikainen H, O’Neil K, Allman S, Millet L, Retterer S, Doktycz M, Standaert R, Boll R, Van Cleve S, DePaoli D, Mirzadeh S. Microfluidics-based separation of actinium-225 from radium-225 for medical applications. SEP SCI TECHNOL 2019. [DOI: 10.1080/01496395.2019.1614956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- Sandra Davern
- Isotope and Fuel Cycle Technology Division, Oak Ridge National Laboratory, Oak Ridge, USA
| | - David O’Neil
- Oak Ridge Associated Universities, Oak Ridge, TN
| | - Hannah Hallikainen
- Oak Ridge Associated Universities, Oak Ridge, TN
- Arizona State University, Tempe, USA
| | | | - Steve Allman
- Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA
| | - Larry Millet
- Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA
- Joint Research Activity, Bredesen Center, University of Tennessee, TN, USA
| | - Scott Retterer
- Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA
- Center for Nanophase Materials Sciences Division, Oak Ridge National Laboratory, Oak Ridge, USA
| | - Mitchel Doktycz
- Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA
- Center for Nanophase Materials Sciences Division, Oak Ridge National Laboratory, Oak Ridge, USA
| | - Robert Standaert
- Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA
- Chemistry, East Tennessee State University, Johnson City, USA
| | - Rose Boll
- Isotope and Fuel Cycle Technology Division, Oak Ridge National Laboratory, Oak Ridge, USA
| | - Shelley Van Cleve
- Isotope and Fuel Cycle Technology Division, Oak Ridge National Laboratory, Oak Ridge, USA
| | - David DePaoli
- Isotope and Fuel Cycle Technology Division, Oak Ridge National Laboratory, Oak Ridge, USA
| | - Saed Mirzadeh
- Isotope and Fuel Cycle Technology Division, Oak Ridge National Laboratory, Oak Ridge, USA
| |
Collapse
|
21
|
Abstract
Application of microfluidics offers numerous advantages in the field of radiochemistry and could enable dramatic reductions in the cost of producing radiotracers for positron emission tomography (PET). Droplet-based microfluidics, in particular, requires only microgram quantities of expensive precursors and reagents (compared to milligram used in conventional radiochemistry systems), and occupies a more compact footprint (potentially eliminating the need for specialized shielding facilities, i.e. hot cells). However, the reported platforms for droplet radiosynthesis have several drawbacks, including high cost/complexity of microfluidic reactors, requirement for manual intervention (e.g. for adding reagents), or difficulty in precise control of droplet processes. We describe here a platform based on a particularly simple chip, where reactions take place atop a hydrophobic substrate patterned with a circular hydrophilic liquid trap. The overall supporting hardware (heater, rotating carousel of reagent dispensers, etc.) is very simple and the whole system could be packaged into a very compact format (about the size of a coffee cup). We demonstrate the consistent synthesis of [18F]fallypride with high yield, and show that protocols optimized using a high-throughput optimization platform we have developed can be readily translated to this device with no changes or re-optimization. We are currently exploring the use of this platform for routine production of a variety of 18F-labeled tracers for preclinical imaging and for production of tracers in clinically-relevant amounts by integrating the system with an upstream radionuclide concentrator.
Collapse
Affiliation(s)
- Jia Wang
- Crump Institute for Molecular Imaging and Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, CA, USA. and Department of Bioengineering, UCLA, Los Angeles, CA, USA
| | - Philip H Chao
- Crump Institute for Molecular Imaging and Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, CA, USA. and Department of Bioengineering, UCLA, Los Angeles, CA, USA
| | - R Michael van Dam
- Crump Institute for Molecular Imaging and Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, CA, USA. and Department of Bioengineering, UCLA, Los Angeles, CA, USA
| |
Collapse
|
22
|
Ginja M, Pires MJ, Gonzalo-Orden JM, Seixas F, Correia-Cardoso M, Ferreira R, Fardilha M, Oliveira PA, Faustino-Rocha AI. Anatomy and Imaging of Rat Prostate: Practical Monitoring in Experimental Cancer-Induced Protocols. Diagnostics (Basel) 2019; 9:E68. [PMID: 31262045 PMCID: PMC6787576 DOI: 10.3390/diagnostics9030068] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2019] [Revised: 06/28/2019] [Accepted: 06/29/2019] [Indexed: 12/16/2022] Open
Abstract
The rat has been frequently used as a model to study several human diseases, including cancer. In many research protocols using cancer models, researchers find it difficult to perform several of the most commonly used techniques and to compare their results. Although the protocols for the study of carcinogenesis are based on the macroscopic and microscopic anatomy of organs, few studies focus on the use of imaging. The use of imaging modalities to monitor the development of cancer avoids the need for intermediate sacrifice to assess the status of induced lesions, thus reducing the number of animals used in experiments. Our work intends to provide a complete and systematic overview of rat prostate anatomy and imaging, facilitating the monitoring of prostate cancer development through different imaging modalities, such as ultrasonography, computed tomography (CT) and magnetic resonance imaging (MRI).
Collapse
Affiliation(s)
- Mário Ginja
- Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal
- Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), 5001-801 Vila Real, Portugal
| | - Maria J Pires
- Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal
- Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), 5001-801 Vila Real, Portugal
| | - José M Gonzalo-Orden
- Department of Medicine, Surgery and Veterinary Anatomy, University of León, 24071 León, Spain
| | - Fernanda Seixas
- Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal
- Animal and Veterinary Research Center (CECAV), 5001-801 Vila Real, Portugal
| | - Miguel Correia-Cardoso
- Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal
| | - Rita Ferreira
- Organic Chemistry, Natural Products and Food Stuffs (QOPNA), 3810-193 Aveiro, Portugal
| | - Margarida Fardilha
- Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal
| | - Paula A Oliveira
- Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal.
- Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), 5001-801 Vila Real, Portugal.
| | - Ana I Faustino-Rocha
- Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), 5001-801 Vila Real, Portugal
- Faculty of Veterinary Medicine, Lusophone University of Humanities and Technologies (ULHT), 1749-024 Lisbon, Portugal
| |
Collapse
|
23
|
Rios A, Wang J, Chao PH, van Dam RM. A novel multi-reaction microdroplet platform for rapid radiochemistry optimization. RSC Adv 2019; 9:20370-20374. [PMID: 35514735 PMCID: PMC9065505 DOI: 10.1039/c9ra03639c] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2019] [Accepted: 06/17/2019] [Indexed: 12/20/2022] Open
Abstract
During the development of novel tracers for positron emission tomography (PET), the optimization of the synthesis is hindered by practical limitations on the number of experiments that can be performed per day. Here we present a microliter droplet chip that contains multiple sites (4 or 16) to perform reactions simultaneously under the same or different conditions to accelerate radiosynthesis optimization. Multi-reaction microdroplet chip enables rapid radiotracer optimization for positron emission tomography.![]()
Collapse
Affiliation(s)
- Alejandra Rios
- Crump Institute of Molecular Imaging, University of California Los Angeles (UCLA) Los Angeles CA USA .,Physics and Biology in Medicine Interdepartmental Graduate Program, UCLA USA
| | - Jia Wang
- Crump Institute of Molecular Imaging, University of California Los Angeles (UCLA) Los Angeles CA USA .,Department of Bioengineering, UCLA USA
| | - Philip H Chao
- Crump Institute of Molecular Imaging, University of California Los Angeles (UCLA) Los Angeles CA USA .,Department of Bioengineering, UCLA USA
| | - R Michael van Dam
- Crump Institute of Molecular Imaging, University of California Los Angeles (UCLA) Los Angeles CA USA .,Physics and Biology in Medicine Interdepartmental Graduate Program, UCLA USA.,Department of Bioengineering, UCLA USA.,Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, UCLA USA
| |
Collapse
|